Simergent is developing the Archimedes automated peritoneal dialysis system, designed to enhance patient mobility and comfort by utilizing lower filling and draining pressures while maintaining precise volume control. This device addresses the challenges of current home dialysis systems, which are often cumbersome and associated with high rates of peritonitis, allowing patients to engage in daily activities without frequent clinic visits.
Funding
$7.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current home dialysis systems are difficult to use and associated with high peritonitis rates. Patients often feel restricted due to a lack of mobility, and experience noise and drain pain.
Solution
Simergent is developing the Archimedes automated peritoneal dialysis system to address the limitations of existing home dialysis options. The system aims to enhance patient mobility and comfort by utilizing lower filling and draining pressures while maintaining precise volume control. Simergent's device incorporates patented features designed to reduce peritonitis and simplify patient training, allowing patients to socialize and engage in daily activities while receiving treatment.
Target Audience
The primary target audience includes patients requiring peritoneal dialysis and healthcare providers specializing in nephrology.
Features
- Automated peritoneal dialysis system for home use
- Lower filling and draining pressures compared to current devices
- Precise volume control during dialysis
- Patented features designed to reduce peritonitis
- User-friendly design for easy patient training